couple of points that madam has made: * zero interest in...

couple of points that madam has made:

* zero interest in Mesoblast's science, and

* zero interest in the technology and that he will select an expert (tuna or Collie?) to advise him on the science and technology.

* He'll start buying at the point that Mesoblast starts producing profits.

So, operating in a science/technology vacuum he'll wait for all possible risk to evaporate and  happily pay the prevailing price at that time?  Wrong tactics Madam. Investors must do some work to understand as best they can the science, technology and therefore the medical opportunity awaiting this stem cell medical revolution and potential profits.

But this is not WOW, or ANZ or TLS - which is his  declared area of comfort and expertise.

No factoring in the consequences of a huge pharma entering into an Agreement with respect to CHF, RA etc etc.

You're out of your depth here madam and you can much better spend your time in the world of retail, banking and telco. And save us from any more of your inappropriate financial/accounting lecturing.